Hyperinsulinemia impairs functions of circulating endothelial progenitor cells
- 136 Downloads
Circulating endothelial progenitor cells (EPCs) play a key role in maintaining endothelial function. Dysfunction of EPCs is associated with the cardiovascular complication of diabetes. The purpose of this study is to investigate the direct effects of hyperinsulinemia on EPCs and the underlying mechanisms.
EPCs isolated from healthy adults were cultured with various concentrations of insulin (control group, without insulin; physiological insulin group, 10 nM insulin and hyperinsulinemia group, 100 nM insulin) with or without phosphatidylinositol-3-kinase (PI3-K) inhibitor (LY294002, 5 µM), endothelial nitric oxide synthase (eNOS) inhibitor (l-NG-nitro-arginine methyl ester (l-NAME), 100 µM), sodium nitroprusside (SNP, 25 µM), p38 mitogen-activated protein kinase(MAPK) inhibitor (SB203580, 5 µM) or extracellular signal-regulated kinases (ERK) 1/2 inhibitor (PD98059, 10 µM). Proliferation, tube formation, and apoptosis of EPCs were determined. Expressions of eNOS, PI3-K, protein kinase B (Akt), p38 MAPK, and ERK 1/2 were assessed.
Hyperinsulinemia caused a significant decrease in proliferation and tube formation abilities than control group. Hyperinsulinemia increased apoptosis rate of EPCs than control group. Furthermore, hyperinsulinemia downregulated phosphorylation of eNOS, PI3-K and Akt, and upregulated phosphorylation of p38 MAPK and ERK. SNP could restore impaired tube formation induced by hyperinsulinemia. P38 MAPK inhibitor but not ERK inhibitor could decrease apoptosis induced by hyperinsulinemia.
Hyperinsulinemia impaired EPCs’ tube formation ability by downregulation of PI-3K/Akt/eNOS pathway. Hyperinsulinemia induced apoptosis of EPCs via upregulation of p38 MAPK.
KeywordsEndothelial progenitor cell Diabetes mellitus Insulin Nitric oxide
This article was supported by Hebei Province technology supporting projects (16277720D).
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
This study was appoved by ethical committee of Qinhuangdao First hospital (2016D005).
All participants provided informed consent prior to their participation.
- 1.Sukmawati D, Tanaka R (2015) Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine. Am J Transl Res 7:411–421Google Scholar
- 7.Breen DM, Chan KK, Dhaliwall JK et al (2009) Insulin increases reendothelialization and inhibits cell migration and neointimal growth after arterial injury. Arterioscler Thromb Vasc Biol 29:1060–1066Google Scholar
- 9.Taguchi K, Sakata K, Ohashi W et al (2014) Tonic Inhibition by G protein–coupled receptor kinase 2 of Akt/endothelial nitric-oxide synthase signaling in human vascular endothelial cells under conditions of hyperglycemia with high insulin levels. J Pharmacol Exp Ther 349:199–208CrossRefGoogle Scholar
- 13.Sheng ZL, Ju CW, Li B et al (2018) TWEAK promotes endothelial progenitor cell vasculogenesis to alleviate acute myocardial infarction via the Fn14NFκB signaling pathway. Exp Ther Med 16:4019–4029Google Scholar
- 15.Schinzari F, Tesauro M, Cardillo C (2018) Increased endothelin-1-mediated vasoconstrictor tone in human obesity: effects of gut hormones. 27:S69–S81Google Scholar
- 18.Chopra H, Hung MK, Kwong DL, Zhang CF, Pow EHN (2018) Insights into endothelial progenitor cells: origin, classification, potentials, and prospects. Stem Cells Int 18:9847015Google Scholar